Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 11 studies | 27% ± 10% | |
| macrophage | 10 studies | 28% ± 9% | |
| classical monocyte | 9 studies | 26% ± 9% | |
| conventional dendritic cell | 8 studies | 27% ± 11% | |
| dendritic cell | 5 studies | 37% ± 15% | |
| plasmacytoid dendritic cell | 5 studies | 26% ± 5% | |
| myeloid cell | 4 studies | 24% ± 6% | |
| monocyte | 4 studies | 26% ± 10% | |
| epithelial cell | 3 studies | 21% ± 2% |
Insufficient scRNA-seq data for expression of NAGA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1817.90 | 459 / 459 | 100% | 57.15 | 1118 / 1118 |
| esophagus | 100% | 1955.81 | 1445 / 1445 | 100% | 43.70 | 183 / 183 |
| kidney | 100% | 1891.61 | 89 / 89 | 100% | 50.29 | 901 / 901 |
| stomach | 100% | 1598.88 | 359 / 359 | 100% | 48.31 | 286 / 286 |
| skin | 100% | 1815.20 | 1808 / 1809 | 100% | 86.55 | 472 / 472 |
| lung | 100% | 2921.07 | 578 / 578 | 100% | 57.07 | 1154 / 1155 |
| thymus | 100% | 1929.74 | 653 / 653 | 100% | 44.95 | 604 / 605 |
| prostate | 100% | 2118.74 | 245 / 245 | 100% | 49.51 | 501 / 502 |
| uterus | 100% | 2390.31 | 170 / 170 | 100% | 51.68 | 458 / 459 |
| bladder | 100% | 2272.90 | 21 / 21 | 100% | 52.34 | 502 / 504 |
| intestine | 100% | 2387.93 | 966 / 966 | 99% | 47.80 | 524 / 527 |
| ovary | 100% | 2169.59 | 180 / 180 | 99% | 34.42 | 427 / 430 |
| liver | 100% | 1776.27 | 226 / 226 | 99% | 44.42 | 400 / 406 |
| brain | 97% | 783.59 | 2556 / 2642 | 99% | 36.44 | 701 / 705 |
| adrenal gland | 100% | 1649.35 | 258 / 258 | 96% | 33.81 | 221 / 230 |
| pancreas | 96% | 755.31 | 314 / 328 | 100% | 52.07 | 178 / 178 |
| adipose | 100% | 2139.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 49.02 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 51.35 | 29 / 29 |
| spleen | 100% | 2683.09 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 53.81 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 28.10 | 1 / 1 |
| blood vessel | 100% | 2196.00 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 2965.43 | 923 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 1177.83 | 847 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 641.12 | 773 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016139 | Biological process | glycoside catabolic process |
| GO_0019377 | Biological process | glycolipid catabolic process |
| GO_0016052 | Biological process | carbohydrate catabolic process |
| GO_0009311 | Biological process | oligosaccharide metabolic process |
| GO_0005764 | Cellular component | lysosome |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008456 | Molecular function | alpha-N-acetylgalactosaminidase activity |
| GO_0004557 | Molecular function | alpha-galactosidase activity |
| GO_0042803 | Molecular function | protein homodimerization activity |
| Gene name | NAGA |
| Protein name | Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) |
| Synonyms | |
| Description | FUNCTION: Removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. Required for the breakdown of glycolipids. . |
| Accessions | ENST00000396398.8 A0A248RGB1 ENST00000403363.5 ENST00000402937.1 P17050 |